This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

John G. Allison, MD, MBChB, FRCS(Ed), FCS(SA)

JAMA. 1981;246(24):2843-2848.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

WITHIN the field of cancer treatment, the most gratifying advances have probably been made in the lymphoma group, especially those of the Hodgkin's type; over the past two decades predicted survival rates have increased dramatically. Newer concepts and understanding of the Hodgkin's group of lymphomas have generated a cautiously optimistic attitude that Hodgkin's disease is eminently curable. Although the hematologistoncologist and radiotherapist bear the brunt of the management, the surgeon can contribute in a meaningful and positive way in both nodal and extranodal disease of all histological types. With this in mind, the classification, staging, and treatment of the lymphomas will be reviewed briefly, as will the role of surgery in the diagnosis, therapy, staging, and post-treatment restaging.

PATHOLOGICAL CLASSIFICATION AND STAGING

The diagnostic feature of Hodgkin's disease is the multinucleated Reed-Sternberg giant cell, with subtyping based on the ratio of other cell types (Table 1). With the exception of . . . [Full Text PDF of this Article]

Author Affiliations
From the Department of Surgery, University of Iowa Hospitals and Clinics, and the Veterans Administration Medical Center, Iowa City.

Footnotes
Reprint requests to Department of Surgery, University of Iowa Hospitals and Clinics, Iowa City, IA 52242 (Dr Allison).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?